Hugemed

About Hugemed

Shenzhen HugeMed Medical Technical Development Co., Ltd. is a manufacturer of medical devices, established in 2014 and headquartered in Shenzhen, China. The company operates as a business-to-business (B2B) manufacturer and supplier, selling its products to hospitals, clinics, and other medical institutions globally. Its revenue model is based on the direct sale of these devices, with an estimated annual revenue between USD 500,001 and 1,000,000. The company has received venture capital funding from investors including Qiming Venture Partners, Credit Guarantee Venture Capital, and Shenzhen Capital Group.

HugeMed focuses on providing endoscopy solutions for various medical departments, including emergency, anesthesiology, ICU, and respiratory care. The company's product portfolio includes both reusable and single-use video endoscopes. The single-use line is a key focus, designed to eliminate the risk of cross-contamination and the need for reprocessing, thereby improving clinical workflow and hospital turnover efficiency. This product line is part of a growing market driven by a global preference for minimally invasive procedures and heightened infection control awareness. Specific products include video laryngoscopes, bronchoscopes, ureteroscopes, cystoscopes, and rhino-laryngoscopes.

Since its founding, HugeMed has achieved several milestones. It launched its first high-definition video laryngoscope in 2015 and obtained ISO & CE certificates in 2016. By 2018, it had become a top exporter of video laryngoscopes and by 2019, its products were sold in over 100 countries. In response to business growth, an office was established in Europe in 2020 to better serve the regional market. The company has received numerous certifications for its products, including CE, FDA, SFDA, and ISO13485, underscoring its commitment to quality and regulatory compliance. This global expansion and adherence to international standards have positioned HugeMed as a notable player in the single-use endoscope market.